Werdnig – Hoffmann spinal muscular atrophy: current therapeutic approaches. A clinical case
Werdnig – Hoffmann spinal muscular atrophy (SMA) is a severe genetic disorder characterized by progressive flaccid paralysis and muscle atrophy. The prevalence of this condition is estimated at 2-7 cases per 100,000 population, with an incidence of approximately 1 in 10,000 live births. As recently as 15 years ago, effective treatment for this disease was not available. Today, several pathogenetic and targeted therapeutic strategies have been developed, resulting in a substantial improvement in the prognosis of children with spinal muscular atrophy.
Authors
- Larina N.G. (ORCID: https://orcid.org/0009-0005-5288-9088)
- Сеченева Людмила Владимировна (ORCID: https://orcid.org/0009-0003-2440-1597)
- A. L. Burova (ORCID: https://orcid.org/0009-0007-4272-3660)
- T. S. Marshilikhina (ORCID: https://orcid.org/0009-0008-5562-735X)
Institutions
- Yaroslav-the-Wise Novgorod State University (RU)
Publication Details
- Journal
- Вестник Новгородского государственного университета им. Ярослава Мудрого
- Published
- 2026-11-19
- DOI
- https://doi.org/10.34680/2076-8052.2026.2(144).252-261
- Primary Topic
- Neurogenetic and Muscular Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00